Radiological, pathological and DNA remission in recurrent metastatic nasopharyngeal carcinoma

被引:5
|
作者
Chan, Stephen L. [1 ]
Hui, Edwin P. [1 ]
Leung, Sing F. [1 ]
Chan, Anthony T. C. [1 ]
Ma, Brigette B. Y. [1 ]
机构
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China
关键词
D O I
10.1186/1471-2407-6-259
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Circulating plasma Epstein Barr Virus DNA (EBV-DNA) is a sensitive and specific marker of nasopharyngeal carcinoma (NPC). The mainstay of treatment of metastatic NPC is systemic chemotherapy and resection for solitary metastasis. Despite high response rate to chemotherapy, complete remission is uncommonly seen. Case Presentation: We report a case of recurrent metastatic NPC in a 43-year-old man, who achieved complete remission three times with chemotherapy and surgery. Serial plasma EBV-DNA levels were measured during the course of disease. The patient had three episodes of recurrences of NPC manifested as distant metastasis. Both time, rise in the plasma EBV-DNA level preceded detection of recurrences by imaging. Following systemic chemotherapy, he achieved complete remission each time, of which was confirmed by 18-flourodeoxyglucose positron emission tomography and hepatectomy pathology. The plasma EBV-DNA level dropped to zero copy/ml at the time of each remission. Conclusion: This case highlights the high chemosensitivity of NPC by illustrating a rare occurrence of complete response of metastatic NPC to chemotherapy. This case also underscores the usefulness of EBV-DNA as a useful tool in monitoring NPC by its ability to detect early recurrence and excellent correlation with treatment response.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] ACUTE BLINDNESS DURING TREATMENT OF RECURRENT OR METASTATIC NASOPHARYNGEAL CARCINOMA WITH DOXORUBICIN AND CCNU
    SCHORNAGEL, JH
    VERWEIJ, J
    DEMULDER, PHM
    WILDIERS, J
    KIRKPATRICK, A
    COGNETTI, F
    EUROPEAN JOURNAL OF CANCER, 1990, 26 (07) : 857 - 857
  • [32] Progress in the clinical development of investigational systemic agents for recurrent and metastatic nasopharyngeal carcinoma
    Yan, Kelvin
    Lim, Darren Wt
    Ma, Brigette B. B. Y.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2024, 33 (10) : 1019 - 1028
  • [33] Detection And Staging Of Recurrent Or Metastatic Nasopharyngeal Carcinoma In The Era Of FDG PET/MR
    Feng, Y.
    Piao, Y.
    Cao, C.
    Xu, Y.
    Hu, Q.
    Chen, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E839 - E839
  • [34] Detection and staging of recurrent or metastatic nasopharyngeal carcinoma in the era of FDG PET/MR
    Piao, Yongfeng
    Cao, Caineng
    Xu, Yuanfan
    Huang, Shuang
    Jiang, Feng
    Jin, Ting
    Jin, Qifeng
    Hua, Yonghong
    Hu, Qiaoying
    Chen, Xiaozhong
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2022, 279 (01) : 353 - 359
  • [35] Palliative Chemotherapy and Targeted Therapy for Recurrent and Metastatic Nasopharyngeal Carcinoma: Reminiscences and the Future
    Lee, V. H. F.
    Kwong, D. L. W.
    HONG KONG JOURNAL OF RADIOLOGY, 2013, 16 (04): : 252 - 260
  • [36] CHEMOTHERAPEUTIC TREATMENT OF RECURRENT AND OR METASTATIC NASOPHARYNGEAL CARCINOMA - A RETROSPECTIVE ANALYSIS OF 40 CASES
    GEBBIA, V
    ZERILLO, G
    RESTIVO, G
    SPECIALE, R
    CUPIDO, G
    LOBUE, P
    INGRIA, F
    GALLINA, S
    SPATAFORA, G
    TESTA, A
    CANNATA, G
    CIMINO, A
    GEBBIA, N
    BRITISH JOURNAL OF CANCER, 1993, 68 (01) : 191 - 194
  • [37] A Phase II Study of Pazopanib in Asian Patients with Recurrent/Metastatic Nasopharyngeal Carcinoma
    Lim, Wan-Teck
    Ng, Quan-Sing
    Ivy, Percy
    Leong, Swan-Swan
    Singh, Onkar
    Chowbay, Balram
    Gao, Fei
    Thng, Choon Hua
    Goh, Boon-Cher
    Tan, Daniel Shao-Weng
    Koh, Tong San
    Toh, Chee-Keong
    Tan, Eng-Huat
    CLINICAL CANCER RESEARCH, 2011, 17 (16) : 5481 - 5489
  • [38] Gemcitabine plus cisplatin for patients with recurrent or metastatic nasopharyngeal carcinoma: a retrospective study
    Kodama, Hiroyuki
    Kadowaki, Shigenori
    Nakata, Akinobu
    Kumanishi, Ryosuke
    Nakazawa, Taiko
    Ogata, Takatsugu
    Matsubara, Yuki
    Honda, Kazunori
    Masuishi, Toshiki
    Narita, Yukiya
    Taniguchi, Hiroya
    Ando, Masashi
    Hanai, Nobuhiro
    Muro, Kei
    ANNALS OF ONCOLOGY, 2022, 33 : S499 - S500
  • [39] A phase II study of axitinib in patients with recurrent or metastatic nasopharyngeal carcinoma (NPC).
    Hui, Edwin Pun
    Ma, Brigette
    Mo, Frankie
    Kam, Michael K. M.
    Chan, Stephen Lam
    Loong, Herbert H. F.
    Ho, Rosalie
    Leung, Sing Fai
    King, Ann Dorothy
    Wang, Ki
    Ahuja, Anil Tejbhan
    Chan, Charles
    Hui, Connie W. C.
    Wong, Chi Hang
    Chan, Anthony T. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [40] Detection and staging of recurrent or metastatic nasopharyngeal carcinoma in the era of FDG PET/MR
    Xu, Yuanfan
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62